Piper Sandler Downgrades The Beauty Health Company (SKIN) to Underweight, 'Too Messy and Too Uncertain'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
The Beauty Health Company (SKIN) plunges on Q3 miss as problems persist
November 14, 2023 9:09 AM ESTThe Beauty Health Company (NASDAQ: SKIN) shares plummeted more than 50% in premarket trading after the company missed consensus third-quarter estimates by a wide margin when it reported after the close on Monday.
The company reported a Q3 loss per share of $0.56, $0.63 worse than the analyst estimate of a profit of $0.07 per share. Meanwhile, revenue for the quarter came in at $97.4 million versus the consensus estimate of $116.23 million.
SKIN, home to flagship brand Hydrafacial, also revised its fiscal year 2023 net sales guidance to a range of $385 to $400 million, its fiscal year... More
JPMorgan Downgrades The Beauty Health Company (SKIN) to Underweight, 'hampered by execution challenges'
November 14, 2023 2:23 AM EST(Updated - November 14, 2023 4:33 AM EST)
JPMorgan analyst Allen Gong downgraded The Beauty Health Company (NASDAQ: SKIN) from Neutral to Underweight.
The analyst comments "We think investors were prepared for a softer quarter from BeautyHealth given the aesthetic prints weve seen to date; however, theres clearly more to unpack from a... More
Canaccord Downgrades The Beauty Health Company (SKIN) to Hold, 'lack of visibility of SKIN returning to growth plan'
November 14, 2023 12:58 AM EST(Updated - November 14, 2023 4:32 AM EST)
Canaccord Genuity analyst Susan Anderson downgraded The Beauty Health Company (NASDAQ: SKIN) from Buy to Hold with a price target of $2.50 (from $10.00).
The analyst comments "On 11/13 after the close, SKIN (Hold, $2.50 PT) reported disappointing 3Q results along with CEO Andrew Stanleick departing. Results were negatively impacted by continued challenges with the earlier versions of the Syndeo system leading to management marking all 1.0 and... More
The Beauty Health Company (SKIN) Misses Q3 EPS by 63c; lowers guidance
November 13, 2023 4:13 PM ESTThe Beauty Health Company (NASDAQ: SKIN) reported Q3 EPS of ($0.56), $0.63 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $97.4 million versus the consensus estimate of $116.23 million.
GUIDANCE:
The Beauty Health Company sees FY2023 revenue of $385-400... More
The Beauty Health Company's (SKIN) President and CEO to Depart
November 13, 2023 4:08 PM ESTThe BeautyHealth Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced that Andrew Stanleick will depart the Company as President & Chief Executive Officer and relinquish his Board seat, effective November 19, 2023. Current BeautyHealth Director Marla Beck will serve as Interim Chief Executive Officer while the Companys Board of Directors completes a formal search for a new CEO.
On behalf of the Board of Directors, I would like to thank Andrew for his leadership and commitment to BeautyHealth. He has been a passionate advocate for the Company, especially adding to its visibility within the... More
